Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Net Margin (2016 - 2025)

Historic Net Margin for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to 12.85%.

  • Bio-Techne's Net Margin rose 11000.0% to 12.85% in Q4 2025 from the same period last year, while for Dec 2025 it was 2.46%, marking a year-over-year decrease of 74000.0%. This contributed to the annual value of 1.82% for FY2025, which is 92100.0% down from last year.
  • Bio-Techne's Net Margin amounted to 12.85% in Q4 2025, which was up 11000.0% from 13.33% recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Net Margin ranged from a high of 4486.7% in Q3 2022 and a low of 21.72% during Q2 2025
  • Moreover, its 5-year median value for Net Margin was 15.66% (2023), whereas its average is 236.65%.
  • As far as peak fluctuations go, Bio-Techne's Net Margin surged by 44599300bps in 2022, and later crashed by -44682900bps in 2023.
  • Bio-Techne's Net Margin (Quarter) stood at 26.76% in 2021, then tumbled by -31bps to 18.41% in 2022, then tumbled by -45bps to 10.08% in 2023, then increased by 17bps to 11.75% in 2024, then increased by 9bps to 12.85% in 2025.
  • Its Net Margin was 12.85% in Q4 2025, compared to 13.33% in Q3 2025 and 21.72% in Q2 2025.